期刊文献+

肝硬化患者外周血及腹水T淋巴细胞亚群的变化及意义 被引量:5

Changes and their significance of T lymphocyte subsets in peripheral blood and ascitic fluid of patients with liver cirrhosis
暂未订购
导出
摘要 目的研究肝硬化患者外周血及腹水T淋巴细胞亚群的变化及意义。方法流式细胞仪测定31例肝炎后肝硬化患者外周血及腹水T淋巴细胞亚群,同时检测15例正常人的外周血T淋巴细胞亚群。结果肝硬化患者外周血T淋巴细胞(CD3+)、T辅助/诱导细胞亚群(CD4+)、T辅助淋巴细胞/T抑制淋巴细胞亚群(CD4+/CD8+)较正常对照明显降低(P<0.01),腹水CD3+、CD4+、CD8+、CD4+/CD8+较外周血显著降低(P<0·001)。结论肝硬化患者外周血及腹水T淋巴细胞亚群存在明显异常,表现为全身及腹膜腔局部的免疫力低下。 Objective To investigate changes and their significance of T lymphocyte subsets in peripheral blood and ascitic fluid of patients with liver cirrhosis. Methods The levels of T lymphocyte subsets in peripheral blood and ascitic fluid were detected by flow cytometer in 31 cases of liver cirrhosis. Fifteen cases of normal person acted as control group. Results The levels of T lymphocyte(CD3^+ ), helper/inducer T lymphocyte(CD4^+ )and ratio of CD4^+/CD8^+ in peripheral blood obviously decreased in peripheral blood of patients with liver cirrhosis compared with those in normal person( P 〈 0.01 ). The levels of CD3^+ , CD4^+ , CD8^+ and CD4^+/CD8 in ascitic fluid in patients were significantly lower than those in peripheral blood ( P 〈 0.01 ). Conclusion The levels of T lymphocyte subsets in peripheral blood and ascitie fluid of patients with liver cirrhosis are obviously abnormal. Systemic immunity and local immunity of peritoneal cavity of patients are weak.
出处 《胃肠病学和肝病学杂志》 CAS 2006年第6期601-602,共2页 Chinese Journal of Gastroenterology and Hepatology
关键词 肝硬化 T淋巴细胞亚群 Liver cirrhosis T lymphocyte subsets
  • 相关文献

参考文献8

二级参考文献16

  • 1病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 2[1]Viallon A, Zeni F, Pouzet V, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis:diagnostic value and relationship to pro-inflammatory cytokines. Intens Care Med, 2000,26 (8):1082-1088.
  • 3[4]American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference:definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992,20(6):864-874.
  • 4[6]Muller B, Pecker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med, 2000,28(3) :977-983.
  • 5[7]Steinwald PM,Whang KT, Becker KL, et al. Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care, 1999,3(1):11-16.
  • 6[8]Reith HB, Lehmkuhl P, Beier W, et al. Procalcionin-ein prognostischer infektions parameter bei der peritonitis. Chir Gastroenterol, 1995, 11 (suppl,2) :47-50.
  • 7[9]Mesner M, Tschaikowsky K, Palmaers T, et al. Comparison of procalcitonin (PCT) and C-reaction protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care, 1999,3 ( 1 ) :45-50.
  • 8Tsuka·motoH.Isinterleukin-10antifibrogenicinchronicliverinjury[].Hepatology.1998
  • 9RossolS,MarinosG,CarucciP,etal.IL -12inductionofTh1 cytokinesisimportantforviralclearanceinchronichepatitisB[].The Journal of Clinical Investigation.1997
  • 10TsaiSL,LiawYF,ChenMH,etal.Detectionoftype-2-likeT -helpercellsinhepatitisCvirusinfection:implicationsformhepatitisviruschronici ty[].Hepatology.1997

共引文献14028

同被引文献56

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部